Looking Ahead in GLP-1 Development

In this concluding episode, the panelists examine emerging trends in GLP-1 receptor agonist therapy and obesity management. They discuss evolving dosing strategies, including cycling, microdosing, and reverse titration, to optimize patient outcomes and mitigate tolerance. The experts highlight the growing focus on weight maintenance, personalized treatment approaches, and the need for ongoing patient education to ensure long-term success after therapy.